G enetics is a young science, with the majority of its principles and mechanisms discovered in the past 50 years. Experimental studies of heredity have been restricted largely to the past 150 years, but an interest in the transmission of characteristics from parent to offspring likely began with the dawn of human consciousness. A rudimentary understanding of heredity began with the initiation of plant cultivation and animal domestication as early as 5000 B.C.E. (Lorentz, Wieben, Tefferi, Whiteman, & Dewald, 2002) .
Greek philosophers of the 6th and 5th centuries B.C.E. speculated on the nature of heredity and debated the causes of birth defects. Hippocrates, Aristotle, and Plato all wrote on human inheritance and noted that some traits were passed in a dominant fashion. Plato observed the danger of "inbreeding" and the susceptibility of the offspring of related or similar parents (Lorentz et aI., 2002) .
In 1859,Darwin published the Origin ofthe Species proposing that organisms evolved through natural selection.The geneticunderpinningof this process,however, was not known until 1900 when four scientists simultaneously and independently "rediscovered" the largely ignored writings of Gregor Mendel, a monk who had published his treatise, Experiments in PlantHybridization, in 1865. One of these scientists,William Bateson, a British zoologist, recognized Mendel's work as the key to understandingDarwin's observation of the evolution of life forms (Lorentzet al., 2(02 
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During the next 50 years a rapid explosion of knowledge and understanding related to genetics occurred. Although students of human disease had noted the differing susceptibility among individuals since the time of Hippocrates, the underlying nature of these differences was not fully appreciated. These observers also noted that certain environmental factors seemed to interact with personal factors and result in illness.
In 1949, Linus Pauling, a chemist, described the specific physicochemical mechanism of sickle cell anemia and linked its cause to a specific mutated gene, providing the first explanation of the genetic susceptibility and phenotypic expression of a human disease at the molecular level (Lorentz et aI., 2002) . Four years later, in 1953, Watson and Crick described the double helical nature of DNA, ushering in the modem era of molecular genetics. The race to characterize the genetic code of human beings and other species had begun, culminating in the announcement of the first draft human genome sequence in February 2001 (Lorentz et al., 2002) .
Sequencing the human genome has led to a number of significant surprises. For example, the entire genetic sequence of a human being, approximately 3 billion base pairs, is largely excess data, with only approximately 1% believed to code for a functional protein or product. Because of the large expanse of DNA and the limited information coded therein, there has been difficulty estimating the actual number of genes, believed to range from 30,000 to 70,000, that exist in the human genome (Tefferi, Wieben, et aI., 2002) . Variation in the genetic sequence among individuals within a species does exist, but the amount of genetic similarity, even among species, is far greater than the differences. These intra-individual variations in a specific location in the sequence are termed mutations if they occur rarely « 1% of the population) and polymorphisms if they are more widely distributed (Tefferi, Wieben, et aI., 2002) .
THE ROLE OF GENES AND ENVIRONMENT IN, DISEASE SUSCEPTIBILITY
Individual differences in disease risk, previously considered to be constitutional or idiopathic, currently seem clearly linked to differing susceptibilities arising from genetic polymorphisms among individuals as -w: ell as the gender, social, racial, and ethnic groups to WhICh individuals belong. For example, the contribution of genetic susceptibility and environmental exposures (including lifestyle factors) playa significant role in the development of cancer, diabetes, heart disease, obesity, and behavioral disorders, and in the varying incidence rates of these diseases among demographic groups (Chiodini & Lewis, 2003; Kopelman, 2000; Shields &Harris, 2000; Zimmet, Alberti, & Shaw, 2001) . Emerging understanding of these genetic predispositions and the effect of environmental influences seem to suggest that many immunological, musculoskeletal, and neurological disorders also share causal roots in gene-environment interaction and the development of disease.
Modem laboratory techniques such as the polymerase chain reaction (PCR), electrophoresis and blotting, genetic recombination, chromosome mapping, microarray technologies, and bioinformatics allow unprecedented access to the structure, function, and variation of the genome (Elkin, 2003; Tefferi, Bolander, Ansell, Wieben, & Spelsberg, 2002; . The identification of specific genetic mutations or polymorphisms and their relationship to the susceptibility, expression, and prognosis of disease, as well as increasingly sophisticated methods of detection, will revolutionize health care practice in the next decade. Molecular diagnostics will allow clinicians to identify individuals who are at increased susceptibility to disease or in a pre-clinical state of the disease, identify variants or sub-types of disease that are not evident phenotypically, and thereby predict response to therapy and prognosis for these variants (Ansell, Ackerman, Black, Roberts, & Tefferi, 2003) .
Because of the hierarchical structure of the encoding and storage of genetic information, it is currently known that the susceptibility to or expression of disease can arise from a number of mechanisms. These include the insertion, duplication, alteration, or deletion of all or part of a chromosome or a single gene. These changes may be inherited from parents or ancestors or may be acquired (arise de novo) during the individual's lifetime. Disease or susceptibility to disease can also arise from changes in the expression (activity) of a normal or variant gene (e.g., turning on or off, or hyper-or hypo-expression). Chromosomal disorders can result in the net loss or gain of genetic information or in translocation of genes to new sites in the genetic sequence, which alters expression. Single gene disorders can arise from single nucleotide substitutions (the most common type of mutation) or from nucleotide deletions and insertions. These muta-DECEMBER 2005, VOL. 53, NO. 12 tions can be silent (i.e., do not change the integrity of the genetic information) or can result in a lethal disease (e.g., a three base pair deletion results in cystic fibrosis). These mutations and polymorphisms can be transmitted through Mendelian (autosomal, recessive, X-linked) or non-Mendelian patterns (triple-repeat, mitochondrial, imprinting or mosaicism) (Ensenauer et al., 2003) .
In particular, as scientists' abilities to understand and profile the genome progress, they begin to recognize the significance of polymorphisms. They currently realize , that many of the differences in individual susceptibility to environmental exposures are the consequence of variants of a gene performing a key enzymatic or structural function. These polymorphisms can result in mild to severe variations in the susceptibility to a particular disease, or may significantly modify the natural history or phenotypic expression of a disease.
The effect of gene polymorphisms on exposure to environmental agents (including dietary exposures) is cogently illustrated in the differing susceptibility to alcohol intoxication among individuals.Associationof these differencesamong racialand ethnic groupsdevelopedintohistoricaland discriminatory racial and ethnic stereotypes related to alcohol tolerance. Withtheadventofmodem laboratorymethods,thebiochemical basisofthesedifferenceswas identified,demonstratingthat the speed of alcohol metabolism, and subsequently alcohol tolerance, is related to differingactivitiesof the alcohol dehydrogenase (ADH) enzyme. Several different variants of the alcohol dehydrogenase enzyme exist in the human species and these genetic polymorphisms are, not surprisingly, associated with race and ethnicity. Interestingly, these alcohol dehydrogenase genotypes are not only associated with susceptibilityto acute intoxication,but are associated with the propensity to alcohol use and dependency possibly explaining, in association with socioeconomic risk factors, the differing risk of alcoholism by race and ethnicity (Bosron, Ehrig, & Li, 1993; Grau, 1996; Higuchi, 1994; Higuchi, Matsushita, Murayama, Takagi, & Hayashida, 1995; Konishi et al. 2003; Li, Yin, Crabb, O'Connor, & Ramchandani, 2001; Segal, 1999; Takeshita, 1999 Takeshita, ,2003 Wall, Carr, & Ehlers, 2003; Wall, Garcia-Andrade, Thomasson, Carr, & Ehlers, 1997) .
Another commonly cited example of how genetic polymorphisms affect the risk of occupational and environmental disease is polymorphisms in the N-acetyltransferase (NATI) gene. Differences in enzyme activity, arising from genetic polymorphisms, correlate strongly with the risk of cancer following exposure to certain industrial and environmental chemicals (e.g., aromatic amines present in tobacco smoke and certain dyes). Studies have demonstrated that individuals with particular polymorphisms for NAT2 (homozygous for the deficient allele) produce enzymes with diminished efficiency (termed slow acetylators) and are at increased risk of developing bladder cancer when exposed to these substances. Approximately 50% of individuals from Western populations are slow acetylators (Ansell et al., 2003) .
Genetic determinants also playa significant role in the mechanism, natural history, and response of diseases that appear phenotypically identical. For example, analysis of multiple myeloma clones using genetic rnicroarray tech-nology has demonstrated significant sub-types of the disease that probably represent differences in cell differentiation and development (Shaughnessy, 2003) . These appear to correlate strongly with response to therapy and clinical course (client survival), but are otherwise phenotypically indistinguishable. Genetic profiling of tumors will almost certainly lead to better prognosis and targeted treatment in the near future (Shaughnessy, 2003) .
GENES AND OCCUPATIONAL AND ENVIRONMENTAL DISEASE
New methods to identify, characterize, and study the expression of genes have permitted explosive growth in research related to genetic influences on occupational and environmental diseases. These studies include the genetic epidemiology of occupational and environmental illness, as well as the ongoing search for useful biomarkers of susceptibility, exposure, and disease. Testing for these biomarkers can include gene sequencing to identify genes and their variants, measurements of gene activity (expression), measurement of the products of a gene (structural proteins and enzymes), measurement of the activity of gene products (enzyme activity or metabolites), or phenotypic markers of gene expression. Although no specific genetic assays for routinely testing occupational and environmental disease susceptibility have been developed or marketed, the rapid pace of research in this field will almost certainly produce such assays in the near future.
Biomarkers ofSusceptibility
Beginning in 1993, Richeldi and Saltini demonstrated that a specific human leukocyte antigen Class II marker (HLA DP) polymorphism (GLU-69) was associated with an increased risk of chronic beryllium disease among exposed workers. Their findings demonstrated the longanticipated ability of scientists to detect specific genetic polymorphisms that could potentially be used to predict individual susceptibility to the toxic effects of industrial compounds (Richeldi et al., 1997; Richeldi, Sorrentino, & Saltini, 1993; Saltini, Amicosante, Franchi, Lombardi, & Richeldi, 1998; Saltini & Richeldi, 1995) .
Since then, a considerable body of published research in relation to the genetic component of several occupational respiratory diseases, including lung cancers, was developed. For example, Borm and Schins (2001) demonstrated that a number of candidate genes exist to predict differing susceptibilities to coal worker's pneumoconiosis. Genes associated with the production of tumor necrosis factor alpha and tumor tissue growth factor beta, were particularly promising. The authors suggested that testing for polymorphisms and phenotypes for these two markers could predict high-and low-risk workers (Borm & Schins, 2001 ). Taylor (2001) reviewed the literature related to the association between genetic factors and the development of asthma. Polymorphisms in HLA Class II alleles were associated with sensitization to low molecular weight antigens. For example, HLA DR3 was associated with sensitivity to trimellitic anhydride and platinum salts, whereas HLA DQBl ASP57 was associated with sensitization to isocyanate compounds (Taylor, 2001) .
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Some genetic polymorphisms may be linked to increased disease susceptibility, but others are linked to increased resistance. For example, some polymorphisms of the gene coding for the enzyme glutathione-s-tranferase (GSTP1) are associated with increased risk for diisocyanate-induced asthma, while one specific GSTPI polymorphism (Val/Val) appears to be protective (odds ratio 0.23, p = 0.07) (Mapp, 2003; Mapp et al., 2002) .
In addition to the influence of specific genes on disease susceptibility and progression, gene-gene interactions also playa significant role in the complex interaction of genes and environmental influences. Gilliland et al. (2002) showed that polymorphisms of the GSTPI gene were also associated with the abnormal methylation of tumor suppressor (PI6) and DNA repair (MGMP) genes resulting in an increased cancer risk from tobacco and radon exposure (Gilliland et aI., 2002) .
Biomarkers ofExposure and Effect
Genetic testing may offer new opportunities for accurate diagnosis and surveillance of occupational disease. It has been long suspected that the carcinogenic mechanisms of some occupational cancers may be substantially different from those of non-occupational cancers. Hirose et aI. (2002) demonstrated that pathologic examination of lung cancers among chromate workers had significantly greater replication error and micro satellite instability findings than lung cancers in un-exposed individuals. This suggested that chromium-induced lung cancers might arise from different mechanisms, or may be pathologically different from those of non-chromate cancers (Hirose et aI., 2002) .
The ability to demonstrate molecular differences in carcinogenesis will have a profound effect on the ability to distinguish occupationally caused cancers from other cancers. Previously, the ability to distinguish an occupational cancer from a non-occupational cancer was largely dependent on causal inference based on workers' prior exposure history. The ability to identify genetic markers of cancer causation could have a significant effect on the occupational epidemiology of cancer, as well as on the legal attribution of cause for workers' compensation.
Genetic monitoring may also provide a significant tool for identifying pre-clinical effects and thereby protecting workers before occupational injury or illness arises. For example, Lu, Jin, Nordberg, and Nordberg (2001) demonstrated that basal and induced metallothionein (MT) might be a biomarker of exposure to cadmium. Further, induced MT expression after exposure to cadmium may be a biomarker of renal susceptibility to cadmiuminduced kidney disease (Lu et al., 2001 ). Currently, surveillance of workers exposed to cadmium depends on the measurement of excreted cadmium in the urine, as well as the excretion of small molecular weight proteins (beta-. 2-microglobulin) as a marker of early renal damage. If workers could be observed for induced metallothionein expression, this may be an early marker of exposure that could result in protective action before renal damage occurs. Expression of other inducible genes may be valuable markers of early toxic exposure.
Genetic monitoring of workers may identify genotoxic effects at levels that are currently considered safe. For example, Laffon, Pasaro, and Mendez (2002) demonstrated significant increases in chromosomal aberrations (e.g., SCE, MN, comet tails) among workers exposed to styrene below the current American Council of Government Industrial Hygienists Threshold Limit Values (Laffon et al., 2002) .
The utility of genetic biomarkers for exposure and effect extends beyond chemical exposures and may include physical and psychological exposures. A study of radiation-exposed workers demonstrated numerous molecular and chromosomal aberrations in the lung biopsies of Chernobyl cleanup workers. Some of the molecular changes observed included the loss of alleles associated with tumor suppression. Those individuals who demonstrated loss of these alleles also demonstrated greater evidence of dysplastic progression, suggesting that genetic susceptibility to cancer may be modified over time based on environmental mutagenesis ' (Chizhikov et aI., 2002) .
Similarly, chromosomal aberrations were eight times more common among a small sample of supersonic transport pilots compared to controls, probably as a consequence of increased exposure to cosmic radiation in flight (Heimers, 2000) . Some authors have suggested that this genetic resistance to radiation-induced cancer may have great relevance to the future exploration of space by the human species. The importance of DNA repair mechanisms on long space voyages may have clinical relevance suggesting that astronauts may be born with greater suitability for these long voyages. That is, of course, not including the science-fiction-like possibility that future generations may be able to genetically engineer or modify individuals with this increased resistance specifically in preparation for space exploration duties.
In a particularly provocative study of the genotoxic effects of workplace exposure, Irie, Asami, Nagata, Miyata, and Kasai (2001) demonstrated that workplace psychological stress is associated with oxidative DNA damage. In a study of office workers, the authors demonstrated the psychological perceptions of workload, stress, and lack of control over workload were significantly associated with elevated DNA adducts in female, but not male, participants. The implications are that psychological stressors in the workplace may have a genotoxic effect leading to increased susceptibility to chronic disease, even cancer, during an individual's lifetime. This direct mutagenic effect, in combination with the immunologic suppression induced by stress, may result in significantly greater risk of these diseases. Hormonal factors or other individual characteristics may modulate that risk (Irie et aI., 2001) .
Genes and Musculoskeletal Injuries
The association between genes and the environment is not limited to rare diseases, uncommon exposures, or occupational diseases, but also includes differing genetic susceptibility to occupational injuries. For example, the genetic predisposition to spinal disorders among certain pedigree dog breeds has been observed for decades. Simi-DECEMBER 2005, VOl.53, NO. 12 larly, human twin studies have shown a strong genetic influence on the development of degenerative disk disease and back pain. Further, familial clustering of degenerative disk disease has been demonstrated in an autosomal dominant pattern. These early observations were confirmed by the publication of a study in 1999 that found that a specific genetic defect (COL982) was associated with degenerative disk disease. This genetic defect substituted the single amino acid tryptophan for glutamine in the alpha-2 chain of collegen-9 (Annunen et al., 1999) . Sub-. sequent studies demonstrated the mutations of COL982, COL2AI, COLlIAl, and COLlIA2 were also associated with disk degeneration in a study of Finnish back pain clients. Among those individuals studied, one of these mutations was present in 4% to 12% of degenerative disk disease cases. Presence of one of these mutations resulted in a three-fold increased risk of degenerative disk disease (Paassilta et aI., 200 I) .
Similarly, mutations in the vitamin D receptor have been associated with abnormal disk signal, disk bulges, and loss of disk height on magnetic resonance imaging (MRI). These vitamin D receptor gene mutations are also associated with an increased incidence of intervertebral disk annular tears on MRI (Videman et al., 1998) . This raises the possibility that one day a genetic or biotech therapy to prevent or reverse intervertebral disk degeneration will be developed ( 
Genes and Neurological Disorders
Studies of families afflicted by hereditary neurological disorders have implicated genetic factors in the development of neurodegenerative disorders and neurobehavioral disorders for centuries. Recent advances in genomic technology, however, have allowed scientists to identify specific genetic markers of susceptibility to injury in the nervous system. Heritable neuropathies, including a rare cause of carpal tunnel syndrome, have been associated with certain chromosomal abnormalities. For example, pressure-induced hereditary neuropathies have been associated with abnormalities of chromosome-17, including duplication or deletion of gene coding for the production of myelin (Potocki et al., 1999) . Amyloid polyneuropathy is associated with mutations in the gene coding for transthyretin (Mochizuki et al., 2001; Zolyomi, Benson, Halasz, Uemichi, & Fekete, 1998) . Familial clustering of carpal tunnel syndrome autosomal dominant pattern has also been observed (Stoll & Maitrot, 1998) .
Certainly, the future is exciting, because of the large number of potential genetic biomarkers of susceptibility, exposure, and effect currently in development. Examples of these emerging discoveries include markers of susceptibility for lung and bladder cancer, fluorosis, silicosis, asbestosis, chronic bronchitis, red cedar asthma, hard metal disease, and solvent and animal allergies. These, and others, will have a revolutionary effect on the conduct of research and the delivery of clinical services related to occupational and environmental exposures.
These new tools present opportunities for protecting the health of workers and communities through improved exposure control and standard setting, surveillance and clinical diagnosis, and treatment and prognostication. Not surprisingly, workers, community members, and their representatives will be skeptical of these claims until their utility is demonstrated and assurances are made that they will be used in a just, ethical, and sensitive manner. Occupational health researchers and providers must be careful not to exaggerate the promise or the pitfalls of genetic research, but to provide a fair, balanced, and informed presentation of the challenges and opportunities of the genomic revolution.
LEGAL AND ETHICALIMPUCATIONS OF GENE-ENVIRONMENT RESEARCH
The emerging availability of genetic markers for susceptibility, exposure, and effect will pose difficult ethical and legal dilemmas (Christiani, Sharp, Collman, & Suk, 2001; Schill, 2000; Schulte, Lomax, Ward, & Colligan, 1999) . Although most scientists would agree that these genetic markers are still in the province of research, there are examples in which these technologies have been successfully and unsuccessfully applied to the surveillance of workers for occupational disease.
This technology burst into the nation's consciousness when Burlington Northern Santa Fe (BNSF) Railroad implemented a genetic screening test for its employees who had filed workers compensation claims for carpal tunnel syndrome. This test was designed to identify a specific rare genetic cause of carpal tunnel syndrome susceptibility. Prompted by a complaint from affected workers, the U.S. Equal Employment Opportunity Commission (EEOC) investigated this testing program and viewed it as a discriminatory work practice. The EEOC filed suit under the Americans with Disabilities Act asking for a preliminary injunction on this activity in February 200 I. The EEOC based its suit on alleged "genetic bias," and noted that this testing had been performed without worker consent or knowledge. Documents submitted by the EEOC suggested that at least one worker had been threatened with dismissal for failing to provide a blood sample for analysis. In April 2001, the suit was settled with an agreed order that prohibited BNSF from continuing its genetic testing program. The EEOC stated that it would "respond aggressively" to future allegations of discrimination based on genetic testing.
Forty-one states currently prohibit genetic discrimination in health insurance. Thirty-one states ban workplace genetic discrimination. The Federal Government's Executive Branch has a specific Executive Order (13145) prohibiting discrimination based on protected genetic information signed by President Clinton on February 8, 2000. None of this legislation, however, addresses the potential conflict between the ban on genetic testing, and the laws governing workers' compensation.
It did not appear that the EEOC ever addressed the BNSF testing program within the context of workers' compensation laws where traditional evidentiary standards have allowed employers to collect or discover any 526 health-related information that reasonably relates to their defense of a claim. This might be an even more important analysis under the workers' compensation system for railroad workers (The Federal Employers' Liability Act), which is not a "no fault" system. Rather it apportions blame and compensates based on the extent to which varying parties are responsible for the injury.
The question remains, "How widespread is genetic testing currently and what can be expected in the future?" The American Management Association (2001) survey noted that 7 of the 2,133 responding employers used genetic testing. A 1997 National Center for Genome Resources survey noted that 85% of workers opposed employer access to genetic information and that 63% of workers stated they would probably not consent to such testing (U.S. Department of Labor, 1998).
Currently, workers who file workers' compensation claims are potentially subjected to a number of examinations and tests that have a profound effect on privacy. These include independent examinations by non-treating providers, laboratory and psychological tests, HIV and drug tests, and hidden camera surveillance. How and why these other investigative techniques are different from genetic testing is largely a reflection of society's perception of the heightened privacy of genetic information. Society must wrestle with the difficult questions that these emerging genomic technologies will pose, particularly in the context of employment and workers' compensation law.
CONCLUSION
The public must be educated about the potential promise, as well as the threats, posed by emerging genetic technologies. Workers can be better protected by the identification of individuals who have increased susceptibility to occupational disease, by the early identification of occupational disease in a pre-clinical state, or by identifying occupational exposure limits that are not adequately protective of workers' genetic material. On the other hand, this knowledge must be balanced by a protection of worker privacy, and the prohibition of potential genetic discrimination on a racial or ethnic basis. Scientists are close to a breakthrough in the understanding of the interactions between genes and the environment. They are poised to enter a world of rapid informational and technological advancement occupational and environmental health practitioners cannot fully anticipate and are ill-prepared to assimilate.
Occupational and Environmental Health in the 21st Century
The New Frontier in Genetics and Disease Prevention 1 2 3 Society is currently on the threshold ofa new revolution in understanding the interaction of genes and the environment.
This research has profound implications for understanding occupational disease and will present ethical challenges to occupational health practice.
The public must be educated about the potential promise, as well as the threats, posed by emerging genetic technologies.
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